Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - Category: Endocrinology Tags: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Source Type: research
More News: Cardiology | Cardiovascular | China Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Empagliflozin | Endocrinology | Heart | Jardiance | Metabolic Syndrome | Obesity